Cargando…
Prognostic and therapeutic TILs of cervical cancer—Current advances and future perspectives
Cervical cancer is a top lethal cancer for women worldwide. Although screening and vaccination programs are available in many countries, resulting in the decline of new cases, this is not true for developing countries where there are many new cases and related deaths. Cancer immunotherapy through ad...
Autores principales: | Tang, Ying, Zhang, Anne X.J., Chen, Guangyu, Wu, Yanheng, Gu, Wenyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430272/ https://www.ncbi.nlm.nih.gov/pubmed/34553029 http://dx.doi.org/10.1016/j.omto.2021.07.006 |
Ejemplares similares
-
Prognostic markers compared to CD3+TIL in locally advanced nasopharyngeal carcinoma
por: Al-Rajhi, Nasser, et al.
Publicado: (2021) -
Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficacy and future vaccine development
por: Meng, X.J
Publicado: (2000) -
The Role of Immunotherapy in the Treatment of Advanced Cervical Cancer: Current Status and Future Perspectives
por: Walsh, Robert J., et al.
Publicado: (2021) -
Editorial: Phytochemicals in cancer prevention and therapeutics: Current advancement and future perspective
por: Pore, Subrata Kumar, et al.
Publicado: (2023) -
High post‐chemotherapy TIL and increased CD4+TIL are independent prognostic factors of surgically resected NSCLC following neoadjuvant chemotherapy
por: Jia, Wenxiao, et al.
Publicado: (2023)